{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-132111","form_type":"8-K","ticker":"AUTL","cik":"0001730463","company_name":"Autolus Therapeutics plc","filed_at":"2025-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.504599+00:00","generated_at":"2026-05-20T04:33:55.155354+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Autolus directors Anderson and Murphy will not stand for re-election at 2025 AGM","bullets":["Joseph Anderson and Martin Murphy notified the board on May 23, 2025, of their decision.","Both directors stated the decision was not due to any disagreement with management or the board.","Their departure takes effect at the 2025 Annual General Meeting of Shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-132111","json":"https://secwatch.observer/filing/0001193125-25-132111.json","markdown":"https://secwatch.observer/filing/0001193125-25-132111.md","text":"https://secwatch.observer/filing/0001193125-25-132111.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1730463/000119312525132111/0001193125-25-132111-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1730463/000119312525132111/d908343d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T04:33:55.155354+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6cb9ba16b3","claim":"Martin Murphy departed as Director at Autolus Therapeutics plc.","evidence_excerpt":"On May 23, 2025, Drs. Joseph Anderson and Martin Murphy, members of the Board of Directors (the “Board”) of Autolus Therapeutics plc (the “Company”), notified the Company of their intention not to stand for re-election at the Company’s 2025 Annual General Meeting of Shareholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1730463/000119312525132111/0001193125-25-132111-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"9627f9ecba","claim":"Joseph Anderson departed as Director at Autolus Therapeutics plc.","evidence_excerpt":"On May 23, 2025, Drs. Joseph Anderson and Martin Murphy, members of the Board of Directors (the “Board”) of Autolus Therapeutics plc (the “Company”), notified the Company of their intention not to stand for re-election at the Company’s 2025 Annual General Meeting of Shareholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1730463/000119312525132111/0001193125-25-132111-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}